Codexis, Inc. - Common Stock (NQ:CDXS)

1.340 +0.050 (+3.88%)

Delayed Quote Updated: 2:47 PM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Codexis, Inc. - Common Stock

< Previous 1 2 3 4 Next >

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

November 05, 2021

Gainers Ontrak (NASDAQ:OTRK) shares rose 21.82% to $11.78 during Friday's pre-market session. The market value of their outstanding shares is at $225.5 million. As per...

Via Benzinga

Codexis Inc (CDXS) Q3 2021 Earnings Call Transcript ↗

November 05, 2021

CDXS earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Up Over 500% in the Last 5 Years, Can This Biotech Continue Its Hot Streak? ↗

October 20, 2021

Codexis is leveraging its core technology to create more effective life science tools.

Via The Motley Fool

Codexis, Merck Extend Supply Pact For Enzyme Used To Manufacture Sitagliptin ↗

September 10, 2021

Codexis Inc (NASDAQ: CDXS) has amended and extended its agreement with Merck & Co Inc (NYSE: MRK) to license and supply a proprietary enzyme used to...

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

September 09, 2021

Gainers IVERIC bio (NASDAQ:ISEE) shares ...

Via Benzinga

Return on Capital Employed Insights for Codexis ↗

August 31, 2021

After pulling data from Benzinga Pro it seems like during Q2, Codexis's (NASDAQ:CDXS) reported sales totaled $25.45 million. Despite a 51.0% in earnings, the company posted a loss...

Via Benzinga

The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO ↗

August 26, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 18, 2021

Gainers Geron (NASDAQ:GERN) shares increased by 53.19% to $2.16 during Friday's regular session. As of 12:33 EST, Geron's stock is trading at a volume of 179.2...

Via Benzinga

58 Biggest Movers From Friday ↗

June 21, 2021

Gainers CAI International, Inc. (NYSE: CAI) shares surged 46.9% to close at $56.05 on Friday after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc....

Via Benzinga

32 Stocks Moving In Friday's Mid-Day Session ↗

June 18, 2021

Gainers CAI International, Inc. (NYSE: CAI) shares jumped 46.4% to $55.86 after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Sykes Enterprises,...

Via Benzinga

The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs ↗

June 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17) 10x Genomics, Inc. (NASDAQ...

Via Benzinga

Codexis Raises 2021 Revenue Outlook After New Order For Its Enzyme Product ↗

June 18, 2021

Codexis Inc (NASDAQ: CDXS) raised its guidance for 2021 following the receipt of a binding purchase order for up to $13.9 million of a proprietary high-performance...

Via Benzinga

28 Stocks Moving in Friday's Pre-Market Session ↗

June 18, 2021

Gainers CAI International, Inc. (NYSE: CAI) rose 45.1% to $55.35 in pre-market trading after the company agreed to a $1.1 billion takeover by Mitsubishi HC Capital Inc. Geron...

Via Benzinga

5 Stocks To Watch For June 18, 2021 ↗

June 18, 2021

Some of the stocks that may grab investor focus today are: Adobe Inc (NASDAQ: ADBE) reported upbeat results for its second quarter and issued strong guidance for the current...

Via Benzinga

Cathie Wood's Ark Loads Up Further On Tesla And Cuts Apple Stake ↗

May 19, 2021

Cathie Wood-led Ark Investment Management on Tuesday snapped up $27.2 million worth of shares in Tesla Inc (NASDAQ: TSLA) after a two-week gap during which shares of the...

Via Benzinga

Cathie Wood Cuts Apple Stake Almost Entirely — And Buys More Coinbase ↗

May 18, 2021

Cathie Wood-led Ark Investment Management on Monday shed nearly all of its stake in Apple Inc (NASDAQ:

Via Benzinga

Cathie Wood Buys $26M Disney Shares And Sells $13M In Netflix: What You Need To Know ↗

May 16, 2021

Cathie Wood-led Ark Investment Management on Friday bought 150,556 shares, worth about $26.15 million, in Walt Disney Co (NYSE: DIS), marking its debut in the media and...

Via Benzinga

Cathie Wood Sheds $33.6M Alibaba Shares On Earnings Day ↗

May 14, 2021

Cathie Wood-led Ark Investment Management on Thursday shed 162,840 shares, worth about $33.6 million, in Alibaba Group Holding (NYSE: BABA) after the company posted its first...

Via Benzinga

Cathie Wood Piles Up Palantir For Third Day In A Row, Adding $39M Worth Of Shares ↗

May 12, 2021

Cathie Wood-led Ark Investment Management on Wednesday snapped up 2.07 million shares, worth about $39 million, in Palantir Technologies Inc (NYSE: PLTR), on a day the...

Via Benzinga

Cathie Wood Loads Up $57M In Palantir As Stock Stages Reversal On Q1 Earnings Beat ↗

May 12, 2021

Cathie Wood-led Ark Investment Management on Tuesday snapped up 2.8 million shares, worth about $56.7 million, in Palantir Technologies Inc (NYSE: PLTR) after the data analytics...

Via Benzinga

Cathie Wood Cuts Apple Stake By 30% And Buys Coinbase, DraftKings ↗

May 10, 2021

Cathie Wood-led Ark Investment Management shed more shares of Apple Inc (NASDAQ:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2021 ↗

April 12, 2021

Upgrades For Eni SpA (NYSE:E), Credit Suisse upgraded the previous rating of Underperform to Neutral. For the fourth quarter, Eni had an EPS of $0.02, compared to year-ago...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.